X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with Abbott India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs ABBOTT INDIA - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS ABBOTT INDIA NOVARTIS/
ABBOTT INDIA
 
P/E (TTM) x 350.6 33.0 1,061.4% View Chart
P/BV x 17.3 8.2 209.2% View Chart
Dividend Yield % 1.7 0.8 205.4%  

Financials

 NOVARTIS   ABBOTT INDIA
EQUITY SHARE DATA
    NOVARTIS
Mar-16
ABBOTT INDIA
Mar-16
NOVARTIS/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs9826,015 16.3%   
Low Rs5563,707 15.0%   
Sales per share (Unadj.) Rs252.91,236.9 20.4%  
Earnings per share (Unadj.) Rs62.1122.2 50.9%  
Cash flow per share (Unadj.) Rs63.3129.0 49.1%  
Dividends per share (Unadj.) Rs10.0035.00 28.6%  
Dividend yield (eoy) %1.30.7 180.6%  
Book value per share (Unadj.) Rs363.6521.2 69.8%  
Shares outstanding (eoy) m31.9621.25 150.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.03.9 77.4%   
Avg P/E ratio x12.439.8 31.1%  
P/CF ratio (eoy) x12.237.7 32.2%  
Price / Book Value ratio x2.19.3 22.7%  
Dividend payout %16.128.6 56.2%   
Avg Mkt Cap Rs m24,580103,296 23.8%   
No. of employees `0000.83.0 25.4%   
Total wages/salary Rs m1,8013,370 53.4%   
Avg. sales/employee Rs Th10,748.98,891.8 120.9%   
Avg. wages/employee Rs Th2,395.21,140.0 210.1%   
Avg. net profit/employee Rs Th2,641.1878.3 300.7%   
INCOME DATA
Net Sales Rs m8,08326,284 30.8%  
Other income Rs m829504 164.4%   
Total revenues Rs m8,91326,789 33.3%   
Gross profit Rs m2343,665 6.4%  
Depreciation Rs m37144 25.4%   
Interest Rs m28 22.2%   
Profit before tax Rs m1,0254,017 25.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m170-   
Extraordinary Inc (Exp) Rs m1,6960-   
Tax Rs m7521,421 52.9%   
Profit after tax Rs m1,9862,596 76.5%  
Gross profit margin %2.913.9 20.8%  
Effective tax rate %73.435.4 207.4%   
Net profit margin %24.69.9 248.7%  
BALANCE SHEET DATA
Current assets Rs m12,67814,446 87.8%   
Current liabilities Rs m2,4334,725 51.5%   
Net working cap to sales %126.737.0 342.7%  
Current ratio x5.23.1 170.4%  
Inventory Days Days3351 63.6%  
Debtors Days Days2220 115.0%  
Net fixed assets Rs m691,113 6.2%   
Share capital Rs m160213 75.2%   
"Free" reserves Rs m11,46010,808 106.0%   
Net worth Rs m11,62111,076 104.9%   
Long term debt Rs m00-   
Total assets Rs m14,40016,241 88.7%  
Interest coverage x570.5497.0 114.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.61.6 34.7%   
Return on assets %13.816.0 86.1%  
Return on equity %17.123.4 72.9%  
Return on capital %23.636.3 64.9%  
Exports to sales %0.70.6 121.1%   
Imports to sales %18.612.6 147.1%   
Exports (fob) Rs m60162 37.3%   
Imports (cif) Rs m1,5033,322 45.2%   
Fx inflow Rs m186268 69.5%   
Fx outflow Rs m1,8213,927 46.4%   
Net fx Rs m-1,635-3,659 44.7%   
CASH FLOW
From Operations Rs m2,5312,514 100.7%  
From Investments Rs m-8,270-800 1,034.4%  
From Financial Activity Rs m-386-803 48.0%  
Net Cashflow Rs m-6,125912 -671.6%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 75.0 100.0%  
Indian inst/Mut Fund % 2.0 7.9 25.3%  
FIIs % 1.6 0.1 1,600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 17.1 125.7%  
Shareholders   41,647 18,270 228.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   AUROBINDO PHARMA  MERCK LTD  SANOFI INDIA  J.B.CHEMICALS  ORCHID PHARMA LTD  

Compare NOVARTIS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Strong; Consumer Durables Stocks Drag(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are trading above the dotted line. Except stocks in the consumer durables sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Aug 23, 2017 03:36 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - STRIDES SHASUN LTD COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS